InflaRx NV (IFRX)
1.44
-0.04
(-2.70%)
USD |
NASDAQ |
May 24, 16:00
1.43
-0.01
(-0.69%)
After-Hours: 20:00
InflaRx Profit Margin (Quarterly): -26.80K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -26.80K% |
| December 31, 2023 | -696.8K% |
| Date | Value |
|---|---|
| September 30, 2023 | -12.26K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-696.8K%
Minimum
Dec 2023
-12.26K%
Maximum
Sep 2023
-245.3K%
Average
-26.80K%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -4.89K% |
| MorphoSys AG | 81.70% |
| BioNTech SE | -168.0% |
| Immatics NV | -10.09% |
| CureVac NV | -570.2% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | -511.9% |
| Operating Margin (Quarterly) | -34.66K% |